ArticleSchizophrenia (Heidelberg, Germany)2026
Revisiting symptom dimensions in schizophrenia with exploratory graph analysis.
Article in Schizophrenia (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Positive and Negative Syndrome Scale (PANSS) groups symptoms into three categories, but factor analyses suggest five dimensions with superior psychometric properties. Exploratory graph analysis (EGA) offers a novel network-based approach that provides additional information such as connection of domains, bridge symptoms, and centrality measures. We applied EGA to PANSS data from 1213 participants with schizophrenia at baseline and after six weeks of treatment. We identified symptom clusters with community detection algorithms, item stability with bootstrapping, and the connecting role of individual items with bridge centrality metrics. EGA consistently revealed five communities: positive symptoms, negative symptoms, cognitive disorganization, depression/anxiety, and hostility/excitement. The latter was less stable and its symptom P6 (suspiciousness) moved to the positive symptom domain at endpoint. Other item assignments were stable, except for items P5 (grandiosity), and G8 (uncooperativeness). P4 (excitement), P6, G8, and G15 (preoccupation) emerged as key bridge symptoms. Overall, the replication of five factors with a different method underlines their clinical importance.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.